InvestorsObserver
×
News Home

Is MEI Pharma Inc (MEIP) Stock at the Top of the Biotechnology Industry?

Friday, November 10, 2023 10:45 AM | InvestorsObserver Analysts

Mentioned in this article

Is MEI Pharma Inc (MEIP) Stock at the Top of the Biotechnology Industry?

A rating of 98 puts MEI Pharma Inc (MEIP) near the top of the Biotechnology industry according to InvestorsObserver. MEI Pharma Inc's score of 98 means it scores higher than 98% of stocks in the industry. MEI Pharma Inc also received an overall rating of 86, putting it above 86% of all stocks. Biotechnology is ranked 52 out of the 148 industries.

Overall Score - 86
MEIP has an Overall Score of 86. Find out what this means to you and get the rest of the rankings on MEIP!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With MEI Pharma Inc Stock Today?

MEI Pharma Inc (MEIP) stock is trading at $7.28 as of 10:24 AM on Friday, Nov 10, a gain of $0.22, or 3.18% from the previous closing price of $7.06. The stock has traded between $7.05 and $7.48 so far today. Volume today is below average. So far 17,491 shares have traded compared to average volume of 35,587 shares. Click Here to get the full Stock Report for MEI Pharma Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App